Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$2.46B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Amazon
AMZN
|
+$1.13B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.78B |
| 2 |
SNDK
Sandisk
SNDK
|
+$949M |
| 3 |
Advanced Micro Devices
AMD
|
+$926M |
| 4 |
Micron Technology
MU
|
+$585M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$509M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Communication Services | 0.62% |
| 3 | Consumer Discretionary | 0.62% |
| 4 | Industrials | 0.48% |
| 5 | Healthcare | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
UDR
UDR
$12.2B
| $11.1M | ﹤0.01% |
278,570
+234,799
| +536% | +$8.68M |
|
3227
Align Technology
ALGN
$11.3B
| $11.1M | ﹤0.01% |
65,925
-35,154
| -35% | -$6.1M |
|
|
ORKA
3228
PUT
Oruka Therapeutics
ORKA
$6.58B
| $11.1M | ﹤0.01% |
116,800
+97,000
| +490% | +$6.46M |
|
3229
MasTec
MTZ
$20B
| $11.1M | ﹤0.01% |
26,689
+14,711
| +123% | +$5.62M |
|
3230
CALL
ASE Group
ASX
$97B
| $11.1M | ﹤0.01% |
246,100
+25,400
| +12% | +$853K |
|
3231
CALL
Iovance Biotherapeutics
IOVA
$3.66B
| $11.1M | ﹤0.01% |
2,667,600
+958,500
| +56% | +$3.64M |
|
3232
Fidelity Enhanced International ETF
FENI
$11.4B
| $11.1M | ﹤0.01% |
+276,515
| New | +$10.9M |
|
3233
Sprott Physical Silver Trust
PSLV
$14.2B
| $11.1M | ﹤0.01% |
588,016
+443,534
| +307% | +$10.4M |
|
3234
PUT
Hudbay
HBM
$13.3B
| $11.1M | ﹤0.01% |
469,700
-25,900
| -5% | -$655K |
|
|
OMDA
3235
CALL
Omada Health Inc
OMDA
$1.47B
| $11.1M | ﹤0.01% |
505,200
+326,000
| +182% | +$5.2M |
|
3236
SiteOne Landscape Supply
SITE
$4.19B
| $11.1M | ﹤0.01% |
96,872
+90,774
| +1,489% | +$11M |
|
3237
PUT
Constellium
CSTM
$3.68B
| $11.1M | ﹤0.01% |
347,400
+186,200
| +116% | +$6.01M |
|
3238
CALL
Xylem
XYL
$26.5B
| $11.1M | ﹤0.01% |
93,600
-201,500
| -68% | -$23.3M |
|
|
3239
Iovance Biotherapeutics
IOVA
$3.66B
| $11.1M | ﹤0.01% |
2,656,740
-340,003
| -11% | -$1.29M |
|
3240
iShares US Utilities ETF
IDU
$1.33B
| $11M | ﹤0.01% |
96,376
+66,214
| +220% | +$7.58M |
|
3241
CALL
Kimco Realty
KIM
$16.1B
| $11M | ﹤0.01% |
435,700
+219,000
| +101% | +$5.25M |
|
3242
PUT
Uranium Energy
UEC
$6.5B
| $11M | ﹤0.01% |
1,035,500
-476,900
| -32% | -$6.4M |
|
3243
CALL
Pinnacle Financial Partners Inc
PNFP
$15.4B
| $11M | ﹤0.01% |
109,300
-31,800
| -23% | -$3.05M |
|
3244
CALL
Trex
TREX
$4.76B
| $11M | ﹤0.01% |
220,200
-9,100
| -4% | -$377K |
|
3245
Becton Dickinson
BDX
$51.8B
| $11M | ﹤0.01% |
72,810
+19,344
| +36% | +$2.89M |
|
3246
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.84B
| $11M | ﹤0.01% |
60,804
+21,303
| +54% | +$4.5M |
|
3247
Argan
AGX
$6.38B
| $11M | ﹤0.01% |
13,793
-16,694
| -55% | -$11.1M |
|
3248
CALL
Healthpeak Properties
DOC
$14.9B
| $11M | ﹤0.01% |
514,000
+17,300
| +3% | +$323K |
|
3249
CALL
Braze
BRZE
$3.47B
| $11M | ﹤0.01% |
507,100
-396,100
| -44% | -$8.82M |
|
3250
CALL
Rhythm Pharmaceuticals
RYTM
$7.7B
| $11M | ﹤0.01% |
99,000
+16,100
| +19% | +$1.46M |
|
Similar funds
Jeff Yass's Q2 2026 Portfolio in Review
As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $142B of net new capital in Q2 2026, opening 1,956 new positions and adding to 5,793 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 2% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.78B trimmed.
- Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
- Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
- Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
- Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
- Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
- Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.